---
search:
  boost: 3
---

# Quinolones

This is a subcategory of Infectious Disease Agents.

## Decision Trees

- [Antibiotics - Quinolones- Non-Preferred (Age Restricted) - Ciprofloxacin Susp](https://forms.office.com.mcas.ms/pages/designpagev2.aspx?origin=OfficeDotCom&lang=en-US&route=GroupForms&subpage=design&id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUQU9BRExVSUFHS1ZGOFRSNjlPREZUNFJHRiQlQCN0PWcu&topview=Preview){ :target="_blank" rel="noopener"}
- [Antibiotics - Quinolones- Non-Preferred - Baxdela, Ciprofloxacin ER, Moxifloxacin, Ofloxacin](https://forms.office.com.mcas.ms/pages/designpagev2.aspx?origin=OfficeDotCom&lang=en-US&route=GroupForms&subpage=design&id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBURFhRQUVUREtSRVkxTVQyVk04S0pVQUJGTiQlQCN0PWcu&topview=Preview){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                        | Generic Name | Quantity | Time (Days) |
| :------------------------------- | :----------- | :------: | :---------: |
| Ciprofloxacin                    |              |          |             |
| Ciprofloxacin Susp <sup>AR</sup> |              |          |             |
| Levofloxacin                     |              |          |             |

### Non-Preferred

| Non-Preferred    | Generic Name | Quantity | Time (Days) |
| :--------------- | :----------- | :------: | :---------: |
| Baxdela          |              |          |             |
| Ciprofloxacin ER |              |          |             |
| Moxifloxacin     |              |          |             |
| Ofloxacin        |              |          |             |

## Authorizations

**Length of Authorizations**: Based on indication

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least **3 days** with at least **one preferred** drug
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Additional Information

- Requests may be authorized if:
    - The infection is caused by an organism resistant to ALL preferred antibiotics (must provide diagnosis and any culture/sensitivity results)
    - The patient is completing a course of therapy that was started in the hospital or other similar location or was started before Medicaid eligibility, only the remaining course will be authorized

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring, **AND** medical necessity for continued use

**AR** - Ciprofloxacin Suspension: a PA is required for patients 12 years and older

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230401_UPDL_Criteria%20_APPROVED.pdf#page=79){ :target="_blank" rel="noopener"}

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230401_UPDL_v7_Approved.pdf#page=26){ :target="_blank" rel="noopener"}

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf){ :target="_blank" rel="noopener"}
